Journal
Blood Advances
Publication Date
7-8-2025
Volume
9
Issue
13
First Page
3293
Last Page
3303
Document Type
Open Access Publication
DOI
10.1182/bloodadvances.2025015855
Rights and Permissions
Yegya-Raman N, Plastaras JP, Wright CM, Chelius M, Zhang S, Baron JA, Hubbeling H, Sim AJ, Robinson TJ, Jain MD, Imber B, Fregonese B, Yahalom J, Ladbury C, Dandapani S, Pinnix CC, Gunther JR, Fang PQ, Wu SY, Dabaja BS, Yang JC, Chew J, Braunstein S, Sinha S, Delinger NM, Sun S, Terezakis SA, Sakthivel G, Constine LS, Chowdhry AK, Reagan PM, Burke S, Tseng YD, LaRiviere MJ, Maity A, Schuster SJ, Chong EA, Figura NB. Bridging radiotherapy before chimeric antigen receptor T cells for B-cell lymphomas: an ILROG multicenter study. Blood Adv. 2025 Jul 8;9(13):3293-3303. doi: 10.1182/bloodadvances.2025015855. © 2025 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Recommended Citation
Yegya-Raman, Nikhil; Yang, Joanna C; and et al., "Bridging radiotherapy before chimeric antigen receptor T cells for B-cell lymphomas: An ILROG multicenter study." Blood Advances. 9, 13. 3293 - 3303. (2025).
https://digitalcommons.wustl.edu/oa_4/5899
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
